Works matching IS 09024441 AND DT 2022 AND VI 109 AND IP 6

Results: 22
    1
    2
    3

    von Willebrand factor activity levels are influenced by driver mutation status in polycythemia vera and essential thrombocythemia patients with well‐controlled platelet counts.

    Published in:
    European Journal of Haematology, 2022, v. 109, n. 6, p. 779, doi. 10.1111/ejh.13866
    By:
    • Iizuka, Kazuhide;
    • Morishita, Soji;
    • Nishizaki, Yuji;
    • Iizuka, Yoshikazu;
    • Iriyama, Noriyoshi;
    • Ochiai, Tomonori;
    • Yanagisawa, Naotake;
    • Yasuda, Hajime;
    • Ando, Jun;
    • Gotoh, Akihiko;
    • Takei, Masami;
    • Hatta, Yoshihiro;
    • Nakamura, Hideki;
    • Nakayama, Tomohiro;
    • Komatsu, Norio
    Publication type:
    Article
    4
    5
    6
    7
    8
    9

    JAK inhibition with ruxolitinib in relapsed or refractory classical Hodgkin lymphoma: Final results of a phase II, open label, multicentre clinical trial (JeRiCHO).

    Published in:
    European Journal of Haematology, 2022, v. 109, n. 6, p. 728, doi. 10.1111/ejh.13859
    By:
    • Gillessen, Sarah;
    • Pluetschow, Annette;
    • Vucinic, Vladan;
    • Ostermann, Helmut;
    • Kobe, Carsten;
    • Bröckelmann, Paul J.;
    • Böll, Boris;
    • Eichenauer, Dennis A.;
    • Heger, Jan‐Michel;
    • Borchmann, Sven;
    • Fuchs, Michael;
    • Borchmann, Peter;
    • Engert, Andreas;
    • von Tresckow, Bastian
    Publication type:
    Article
    10

    Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B‐cell lymphoma.

    Published in:
    European Journal of Haematology, 2022, v. 109, n. 6, p. 719, doi. 10.1111/ejh.13858
    By:
    • Daniel, Adrien;
    • Ghez, David;
    • Ravaiau, Camille;
    • Cavalieri, Doriane;
    • Tournilhac, Olivier;
    • Herbaux, Charles;
    • Roriz, Mélanie;
    • Wemeau, Mathieu;
    • Guillet, Stéphanie;
    • Bossard, Jean Baptiste;
    • Hélène, Demarquette;
    • Kaphan, Eleonore;
    • Caroline, Regny;
    • Florence, Lachenal;
    • Pierache, Adeline;
    • Michel, Marc;
    • Godeau, Bertrand;
    • Terriou, Louis
    Publication type:
    Article
    11

    5′‐nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate‐risk cytogenetics.

    Published in:
    European Journal of Haematology, 2022, v. 109, n. 6, p. 755, doi. 10.1111/ejh.13862
    By:
    • Díaz‐Santa, Johana;
    • Rodríguez‐Romanos, Rocío;
    • Coll, Rosa;
    • Osca, Gemma;
    • Pratcorona, Marta;
    • González‐Bártulos, Marta;
    • Garrido, Ana;
    • Angona, Anna;
    • Talarn, Carme;
    • Tormo, Mar;
    • Arnan, Montserrat;
    • Vives, Susanna;
    • Salamero, Olga;
    • Tuset, Esperanza;
    • Lloveras, Natàlia;
    • Díez, Isabel;
    • Zamora, Lurdes;
    • Bargay, Joan;
    • Sampol, Antonia;
    • Cruz, David
    Publication type:
    Article
    12
    13
    14

    Activated prothrombin complex concentrate to treat bleeding events in acquired hemophilia A: BAHAS study.

    Published in:
    European Journal of Haematology, 2022, v. 109, n. 6, p. 686, doi. 10.1111/ejh.13853
    By:
    • Mingot‐Castellano, María E.;
    • García‐Candel, Faustino;
    • Benítez‐Hidalgo, Olga;
    • Marco, Ana;
    • Méndez Navarro, Gala A.;
    • Pérez‐Montes, Rocío;
    • García Donas, Gloria;
    • Canaro, Mariana;
    • Paloma, María J.;
    • Asenjo, Beatríz;
    • Calle‐Gordo, Victoria M.;
    • González, Noelia P.;
    • Rodríguez González, Ramón;
    • Caparrón‐Miranda, Isabel S.;
    • Quintana París, Laura;
    • Herrero, Sonia;
    • Nuñez, Ramiro
    Publication type:
    Article
    15
    16
    17
    18
    19
    20

    Issue Information.

    Published in:
    European Journal of Haematology, 2022, v. 109, n. 6, p. 599, doi. 10.1111/ejh.13662
    Publication type:
    Article
    21
    22